Clinical Trials

120 enrolled

Cholangiocarcinoma

NCT07454486 2026-03-06

TRACE-BTC

300 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

NCT07432568 2026-02-25

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

30 enrolled

Cholangiocarcinoma

NCT07401485 2026-02-10

MAAGIE

100 enrolled

Cholangiocarcinoma

NCT07353827 2026-01-20

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

36 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07344116 2026-01-15

Hepatobiliary and Pancreatic Tumor Biobank

300 enrolled

Pancreatic Neoplasms, Cholangiocarcinoma

NCT07296666 2025-12-22

Adjuvant Chemotherapy for BTC Based on 3D-PTA

98 enrolled

Phase 1/2 Not yet recruiting

Cholangiocarcinoma

NCT07269158 2025-12-08

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

160 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT07208526 2025-10-06

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

270 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07206355 2025-10-03

Map HPB

160 enrolled

Biliary Tract Neoplasms, Pancreatic Cyst, Pancreatic Neoplasms, Cholangiocarcinoma

NCT07161869 2025-09-09

POELH-III

250 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Biliary Tract Neoplasms, Common Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07128290 2025-08-17

PEHRICCA

49 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07115420 2025-08-11

Opti-LAMS

100 enrolled

Cholangiocarcinoma

NCT07064447 2025-07-14

Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator

260 enrolled

Pancreatic Neoplasms, Cholangiocarcinoma, Choledocholithiasis

NCT06780553 2025-06-29

PROFI-CHOL

60 enrolled

Disease, Cholangiocarcinoma

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

38 enrolled

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06946849 2025-04-27

SED-RO-ICC

76 enrolled

Phase 2/3 Not yet recruiting

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06923475 2025-04-11

NEODISCO

150 enrolled

Cholangiocarcinoma, Klatskin Tumor

NCT06623734 2025-03-06

Liver Cancer Prognosis Investigation Study

5,000 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma

NCT06651346 2025-01-30

Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples

100 enrolled

Cholangiocarcinoma

NCT06670547 2024-11-01

Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

3,000 enrolled

Biliary Fistula, Cholangitis, Sclerosing, Cholangiocarcinoma, Choledocholithiasis

NCT06658587 2024-10-26

A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma

60 enrolled

Disease, Cholangiocarcinoma, Klatskin Tumor

NCT06648525 2024-10-18

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

68 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06567600 2024-08-22

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

43 enrolled

Cholangiocarcinoma

NCT06539377 2024-08-06

LIVINCA

6 enrolled

Cholangiocarcinoma

NCT06530823 2024-07-31

Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma

38 enrolled

Phase 1 Not yet recruiting

Cholangiocarcinoma

NCT06490198 2024-07-08

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

30 enrolled

Phase 4 Not yet recruiting

Cholangiocarcinoma

NCT06417606 2024-05-22

Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma

20 enrolled

Cholangiocarcinoma

NCT06375642 2024-04-19

A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC

30 enrolled

Cholangiocarcinoma

NCT06369896 2024-04-17

Spy+IDUS

36 enrolled

Cholangiocarcinoma

NCT06313554 2024-03-15

Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic Cholangiocarcinoma

63 enrolled

Cholangiocarcinoma

NCT06175845 2023-12-19

ACTICCA-2

130 enrolled

Bile Duct Neoplasms, Bites and Stings, Cholangitis, Liver Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT05896956 2023-06-09

The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases

500 enrolled

Bile Duct Neoplasms, Biliary Tract Diseases, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Gallstones

NCT05644743 2022-12-09

Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma

40 enrolled

Cholangiocarcinoma

NCT04824742 2021-04-01

Neoadjuvant PDT in the Treatment of Cholangiocarcinoma

50 enrolled